AMRX Amneal Pharmaceuticals

• None no insider bought on the open market
• $9.8M sold by 5 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. John Kiely Director
   Sale
   $882K 50,000 shares at $17.64 19% of stake
   Traded Aug 13 Filed Aug 14
   ↗
3. Nikita Shah Executive Vice President
   Sale
   $2.6M 146,403 shares at $17.51 37% of stake
   Traded Aug 12 Filed Aug 13
   ↗
4. Jason B. Daly EVP, Chief Legal Officer
   Sale
   $3.8M 216,613 shares at $17.41 86% of stake
   Traded Aug 11–12 Filed Aug 13
   ↗
5. Deborah M. Autor Director
   Sale
   $451K 34,819 shares at $12.94 27% of stake
   Traded May 11 Filed May 12
   ↗
6. Ted C Nark Director
   Sale
   $586K 50,000 shares at $11.72 15% of stake
   Traded Nov 17, 2025 Filed Nov 19, 2025
   ↗
7. Nikita Shah Executive Vice President
   Sale
   $1.6M 131,856 shares at $11.92 47% of stake
   Traded Nov 12, 2025 Filed Nov 14, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 38 option exercises, 26 share withholdings for taxes, 4 stock grants, and 4 gifts.